Impact of Inspired Oxygen Fraction on Outcome in Patients With Traumatic Brain Injury
NCT ID: NCT01201291
Last Updated: 2018-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
67 participants
INTERVENTIONAL
2010-11-30
2018-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Between Different Types of Oxygen Treatment Following Traumatic Brain Injury
NCT00170352
ROS in TBI Patients in Relation to Level of Oxygenation.
NCT05101278
Study of Cerebral Tissue Oxygenation During Transfusion in Traumatic Brain Injury
NCT01728831
The Safety and the Efficiency of Hyperbaric Oxygen in Traumatic Brain Injury
NCT06816199
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
NCT00974259
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary outcome is worse than expected outcome in the corresponding treatment arms based on outcome meas-ured by the probability of bad outcome using the CRASH® risk calculator (prognostic model for predicting outcome after traumatic brain injury).
Secondary outcome is occurence of lung injury during mechanical ventilation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fraction of inspired oxygen of 0.4
Fraction of inspired normobaric oxygen of 0.4 (low oxygen group)
Normobaric oxygen
Fraction of inspired oxygen
Fraction of inspired oxygen of 0.7
Fraction of inspired normobaric oxygen of 0.7 (high oxygen group)
Normobaric oxygen
Fraction of inspired oxygen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Normobaric oxygen
Fraction of inspired oxygen
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Multiple trauma patient with brain injury and traumas outside abdomen, thorax or pelvis not affecting oxygenation
* Glasgow coma scale eight or less (inclusive)
* Expected need for intubation and for mechanical ventilation more than 24 hours.
* Are recruited \<18 hours after admittance to ICU and
* Time from TBI is less than 36 hours
* Informed consent from patients representative
Exclusion Criteria
* Anticipated brain death in 12 hours (donor treatment) or otherwise moribund patient expected to die in 24 hours
* Expected need for mechanical ventilation less than 24 hours
* Insufficient oxygenation assessed by a clinician or multiple trauma patients with brain injury and severe abdominal, thoracic or pelvic injury possibly affecting oxygenation.
* No consent
* Insufficient oxygenation with the treatment modality of the lower oxygenation group (Pa02 less than 13 kPa or SpO2 95% with Fi02 40%, PEEP 10 or less) or oxygenation failure probable during ICU care (severe aspiration, multiple trauma patients with brain injury and severe abdominal, thoracic or pelvic injury possibly affecting oxygenation)
* Penetrating TBI
* No consent
* Suspected pregnancy (perform urinary or serological pregnancy test if suspected)
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tampere University Hospital
OTHER
Turku University Hospital
OTHER_GOV
Helsinki University Central Hospital
OTHER
Kuopio University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stepani Bendel
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Esko Ruokonen, Professor
Role: PRINCIPAL_INVESTIGATOR
Kuopio University Hospital
Stepani J Bendel, MD,PhD
Role: STUDY_DIRECTOR
Kuopio University Hospital
Maarit Lång, MD
Role: PRINCIPAL_INVESTIGATOR
Kuopio University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Helsinki University Central Hospital, Töölö Hospital
Helsinki, Töölö, Finland
Kuopio University Hospital
Kuopio, , Finland
Tampere University Hospital
Tampere, , Finland
Turku University Hospital
Turku, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KUH5070218
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.